Last update :
29/10/2024
References   References 3138  
Type : Manufacturer

Research teams :
Authors :
Title : Ofatumumab (Arzerra®) - Summary of Product Characteristics
Reference : GlaxoSmithKline 2009

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionOfatumumab Anticancer drug
Stability in solutions Not specified Sodium chloride 0,9% 0,3 mg/ml <25°C Not specified
48 Hour
Stability in solutions Not specified Sodium chloride 0,9% 2 mg/ml <25°C Not specified
48 Hour

  Mentions Légales